[An epidemiological study of hypercholesterolemia in the Grand Duchy of Luxembourg].
Epidemiology of hypercholesterolemia in the Grand Duchy of Luxembourg was studied by the mean of a questionnaire filled out by 17 physicians. 113 patients (50 men and 63 women) were recruited. 43 patients had an isolated hypercholesterolemia (type IIa) and 63 patients had a type IIb. Analysis of associated risk factors showed large variations (13.2% of patients had diabetes, 61% were sedentary). However, 33.5% of patients had at least one associated risk factor. The nutritional assessment showed the well-known dietary errors. A two month's treatment with ciprofibrate has shown a 20% decrease of total cholesterol and a 32% decrease of triglycerides. No serious adverse events were reported.
Michel
G
G
Département d'Endocrinologie, Centre Hospitalier, Luxembourg.
Bouckaert
A
A
D000328:Adult; D000368:Aged; D008078:Cholesterol, LDL / Q000097:blood; D015243:Cholesterol, VLDL / Q000097:blood; D002995:Clofibric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D004812:Epidemiologic Methods; D005260:Female; D058607:Fibric Acids; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy / Q000453:epidemiology*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008189:Luxembourg / Q000453:epidemiology; D008297:Male; D008875:Middle Aged
D008078:Cholesterol, LDL; D015243:Cholesterol, VLDL; D058607:Fibric Acids; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; C019304:ciprofibrate
Une étude épidémiologique de l'hypercholestérolémie au Grand-Duché de Luxembourg.